News & Analysis as of

Medical Devices › Pharmaceutical Industry › Tobacco Regulations

Latham & Watkins LLP

New FDA Brief in Supreme Court Tobacco Case Puts Spotlight on Post-Chevron Regulatory Landscape

Latham & Watkins LLP on

FDA says its authority to implement the TCA is not limited by Loper Bright, but suggests that future guidance documents may be limited. On August 26, 2024, the US Food and Drug Administration (FDA or the Agency) filed its...more

Skadden, Arps, Slate, Meagher & Flom LLP

FDA Announces That Domestic Inspections Will Resume

Skadden, Arps, Slate, Meagher & Flom LLP on

On July 10, 2020, the Food and Drug Administration (FDA or the Agency) announced plans to resume domestic facility inspections following the March 2020 suspension of most foreign and domestic facility inspections as a result...more

Downs Rachlin Martin PLLC

Vermont Health Care Update 02-17-2020 - An analysis from DRM's Health Law Team

Downs Rachlin Martin PLLC on

Push to end surprise medical billing - The Senate Finance Committee heard from providers and health insurers on S.309, a bill that prohibits certain provisions in contracts between health insurers and health care...more

BakerHostetler

FDA and Pharmacy Weekly Digest - January 2020 #3

BakerHostetler on

Food/Dietary Supplements - FDA Issues Statement on E. coli in Lettuce – FDA issued an update to the E. coli O157:H7 illnesses linked to romaine lettuce....more

BakerHostetler

FDA and Pharmacy Weekly Digest - September 2019 #4

BakerHostetler on

Food/Dietary Supplements - FDA to Hold Public Meeting on Food Standards of Identity – The FDA will hold a public meeting “to give interested persons an opportunity to discuss FDA’s effort to modernize food standards of...more

BakerHostetler

FDA and Pharmacy Weekly Digest - April 2019 #1

BakerHostetler on

Food/Dietary Supplements - Public Meeting on Intentional Adulteration Rule – On April 17, 2019, the U.S. Food and Drug Administration (FDA) will hold a public meeting on the draft guidance it issued related to the...more

Hogan Lovells

FDA Begins Reorganization that Will Affect How it Regulates Medical Technology

Hogan Lovells on

What impact will the U.S. Food and Drug Administration’s significant reorganization efforts have on how the agency regulates medical technology? The agency is reorganizing the Office of Regulatory Affairs (ORA) and combining...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide